Syndax Pharmaceuticals Inc
NASDAQ:SNDX

Watchlist Manager
Syndax Pharmaceuticals Inc Logo
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Watchlist
Price: 9.05 USD 1.12% Market Closed
Market Cap: 778.7m USD
Have any thoughts about
Syndax Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

SNDX Price Targets Summary
Syndax Pharmaceuticals Inc

Wall Street analysts forecast SNDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNDX is 35.51 USD with a low forecast of 16.16 USD and a high forecast of 53.55 USD.

Lowest
Price Target
16.16 USD
79% Upside
Average
Price Target
35.51 USD
292% Upside
Highest
Price Target
53.55 USD
492% Upside
Syndax Pharmaceuticals Inc Competitors:
Price Targets
ORY
Oryzon Genomics SA
185% Upside
CRNX
Crinetics Pharmaceuticals Inc
148% Upside
MRNA
Moderna Inc
77% Upside
1952
Everest Medicines Ltd
13% Upside
4593
Healios KK
8% Upside
STTK
Shattuck Labs Inc
128% Upside
603087
Gan & Lee Pharmaceuticals
22% Upside
EXAS
Exact Sciences Corp
24% Upside

Revenue
Forecast

Revenue Estimate
Syndax Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Syndax Pharmaceuticals Inc's revenue is 45%. The projected CAGR for the next 3 years is 143%.

45%
Past Growth
143%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Syndax Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Syndax Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNDX's stock price target?
Price Target
35.51 USD

According to Wall Street analysts, the average 1-year price target for SNDX is 35.51 USD with a low forecast of 16.16 USD and a high forecast of 53.55 USD.

What is Syndax Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
143%

For the last 8 years the compound annual growth rate for Syndax Pharmaceuticals Inc's revenue is 45%. The projected CAGR for the next 3 years is 143%.

Back to Top